Anixa Biosciences Inc
Anixa Biosciences Inc
Anixa Biosciences Inc (ANIX) — SEC Financial Statements & Analysis
Anixa Biosciences Inc (ANIX) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | |||||
Short Term Investments | 12 | 13 | 14 | 15 | 14 | 16 | 19 | 20 | 22 | 23 | 23 | 22 | |||||
Receivables Net Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | |||||
Assets Current | 15 | 15 | 16 | 17 | 17 | 19 | 21 | 23 | 24 | 25 | 25 | 26 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 15 | 15 | 16 | 18 | 17 | 19 | 22 | 23 | 24 | 25 | 26 | 27 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Accrued Liabilities Current | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 2 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 2 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 271 | 269 | 267 | 265 | 262 | 261 | 260 | 259 | 258 | 256 | 252 | 251 | |||||
Retained Earnings Accumulated Deficit | -257 | -254 | -252 | -249 | -247 | -244 | -241 | -238 | -235 | -231 | -228 | -226 | |||||
Treasury Stock Value | - | - | - | - | - | -0 | -0 | - | - | - | - | - | |||||
Stockholders Equity | 13 | 14 | 15 | 15 | 15 | 17 | 19 | 21 | 23 | 24 | 24 | 26 | |||||
Minority Interest | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Liabilities And Stockholders Equity | 15 | 15 | 16 | 18 | 17 | 19 | 22 | 23 | 24 | 25 | 26 | 27 | |||||
Preferred Stock Par Or Stated Value Per Share | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 34 | 33 | 33 | 33 | 32 | 32 | 32 | 32 | 32 | 32 | 31 | 31 | |||||
Shares Outstanding | 34 | 33 | 33 | 33 | 32 | 32 | 32 | 32 | 32 | 32 | 31 | 31 | |||||
Treasury Stock Common Shares | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.43% | 5.37% | -9.40% | 39.15% | - | - | - | - | - | - | - | - |
| 2025 | -4.89% | 4.51% | -3.38% | 33.07% | 35.43% | 16.93% | 8.28% | 36.75% | 51.99% | -6.33% | -9.81% | -19.30% |
| 2024 | 3.90% | -4.55% | -21.10% | -13.33% | 19.61% | 24.71% | -0.62% | 1.25% | -0.31% | 28.89% | 40.00% | 32.00% |
| 2023 | - | - | - | -8.90% | 15.03% | 11.66% | -7.37% | -13.88% | -16.15% | -10.16% | -35.26% | -36.25% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 9.79 | 12.18 | 8.08 | 8.45 | 8.89 | 9.35 | 8.54 | 11.31 | 14.40 | 15.19 | 12.50 | 14.22 | |||||
| Quick Ratio | 9.16 | 11.49 | 7.71 | 7.76 | 8.27 | 8.63 | 8.04 | 10.56 | 13.95 | 14.57 | 11.89 | 13.93 | |||||
| Working Capital | 13.19M | 13.81M | 13.92M | 15.38M | 14.88M | 16.69M | 18.86M | 20.67M | 22.53M | 23.56M | 23.33M | 24.54M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.12 | 0.10 | 0.15 | 0.15 | 0.14 | 0.13 | 0.14 | 0.11 | 0.08 | 0.07 | 0.09 | 0.08 | |||||
| Debt Ratio | 0.11 | 0.09 | 0.13 | 0.13 | 0.12 | 0.12 | 0.13 | 0.10 | 0.07 | 0.07 | 0.08 | 0.07 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | |||||
| Days Sales Outstanding TTM | - | - | - | - | - | - | - | - | - | 467.55 | 274.62 | 580.52 | |||||
| Receivables Turnover TTM | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.78 | 1.33 | 0.63 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.30 | -0.31 | -0.34 | -0.34 | -0.38 | -0.39 | -0.39 | -0.39 | -0.36 | -0.34 | -0.32 | -0.34 | |||||
| Free Cash Flow Per Share TTM | -0.42 | -0.43 | -0.45 | -0.44 | -0.34 | -0.25 | -0.23 | -0.26 | -0.22 | -0.21 | -0.20 | -0.19 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | - | - | - | - | - | - | - | - | -5,744.76% | -5,243.33% | -5,509.05% | |||||
| Net Profit Margin TTM | - | - | - | - | - | - | - | - | - | -5,116.19% | -4,671.90% | -5,011.43% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | - | - | - | - | - | -100.00% | -100.00% | -100.00% | -100.00% | - | - | -140.86% | |||||
| Net Income Growth (1Y) | -18.09% | -17.85% | -12.96% | -9.48% | 5.10% | 16.46% | 27.96% | 17.46% | 7.48% | -11.12% | -27.83% | -26.34% | |||||
| EPS Growth (1Y) | -21.48% | -20.42% | -14.45% | -10.66% | 4.16% | 13.74% | 24.28% | 13.50% | 4.17% | -12.60% | -29.25% | -27.58% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -10.10 | -9.83 | -12.27 | -8.88 | -7.37 | -7.46 | -8.89 | -8.61 | -8.17 | -13.29 | -9.98 | -10.57 | |||||
| P/B | 7.62 | 7.30 | 9.61 | 6.45 | 6.03 | 5.59 | 5.91 | 5.14 | 4.20 | 6.05 | 4.19 | 4.36 | |||||
| P/S TTM | - | - | - | - | - | - | - | - | - | 679.83 | 466.18 | 529.51 | |||||
| Market Cap | 100.78M | 101.05M | 134.04M | 99.38M | 89.84M | 93.37M | 111.64M | 106.42M | 94.78M | 142.76M | 97.90M | 111.20M | |||||
| Enterprise Value | 99.30M | 99.50M | 132.79M | 97.88M | 87.93M | 92.32M | 110.37M | 105.19M | 93.79M | 141.77M | 96.98M | 108.00M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -14.13M | -14.19M | -14.48M | -14.16M | -10.88M | -7.93M | -7.34M | -8.38M | -7.18M | -6.53M | -6.21M | -5.83M | |||||
| Net Debt | -1.48M | -1.55M | -1.24M | -1.50M | -1.91M | -1.05M | -1.27M | -1.23M | -995.00K | -998.00K | -915.00K | -3.20M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data